Frostbite
diseaseOn this page
Summary
Frostbite (MONDO:0800177) is a disease and 8 clinical trials. Top therapeutic interventions include dalbavancin, oxygen, and aloe. A subtype of injury — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 8
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | frostbite |
| Mondo ID | MONDO:0800177 |
| ICD-10-CM | T33-T34 |
| ICD-11 | 152692065 |
| NCIT | C34627 |
| SNOMED CT | 370977006 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of injury. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: injury › frostbite
Related subtypes (9): ischemia reperfusion injury, bone fracture, acute lung injury, spinal injury, radiation injury, burn, ankle injury, nervous system injury, head injury
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 8.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 5 |
| PHASE4 | 3 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06266494 | PHASE4 | RECRUITING | Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis |
| NCT07240649 | PHASE4 | NOT_YET_RECRUITING | Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications |
| NCT07424378 | PHASE4 | NOT_YET_RECRUITING | Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO) |
| NCT05777590 | Not specified | ACTIVE_NOT_RECRUITING | Comparison of ICG Microangiography and Conventional Angiography in Severe Frostbite |
| NCT07450469 | Not specified | NOT_YET_RECRUITING | Field Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude |
| NCT03405467 | Not specified | COMPLETED | 10-years Nationwide Alpine Accidents in Austria |
| NCT04633174 | Not specified | COMPLETED | Sous Vide Rewarming for Frostbitten Extremities |
| NCT05280301 | Not specified | COMPLETED | Multicenter Sous Vide Frostbite |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| DALBAVANCIN | 4 | 1 |
| OXYGEN | 4 | 1 |
| ALOE | 3 | 1 |
| CHEMBL4778239 | 0 | 1 |
| CHEMBL4785392 | 0 | 1 |
| CHEMBL6174705 | 0 | 1 |
Related Atlas pages
- Drugs: Dalbavancin, Oxygen, Aloe